Pricing

FLAGSHIP PIONEERING INC.

1 follower ·
CAMBRIDGE MA Investment Advisor
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Flagship Pioneering is based out of Cambridge. Flagship Pioneering is a registered investment advisory firm Their last reported 13F filing for Q4 2023 included $1,325,311,872 in managed 13F securities and a top 10 holdings concentration of 100.0%. Flagship Pioneering's largest holding is Moderna Inc with shares held of 9,666,038. Whalewisdom has at least 30 13F filings, and 4 Form 4 filings

2023-12-31

Top Buys (13F)

Name % Change
SYRS Syros Pharmaceutical 0.48%

2023-12-31

Top Sells (13F)

Name % Change
EVLO Evelo Biosciences In 2.26%
AXLA Axcella Health Inc 0.89%
DNLI Denali Therapeutics 0.17%

2023-12-31

13F Holdings Summary

Name $ Change
MRNA Moderna Inc 72.53%
SANA Sana Biotechnology I 7.7%
OMGA Omega Therapeutics I 6.64%
FHTX Foghorn Therapeutics 6.17%
DNLI Denali Therapeutics 3.76%

2023-12-31

13F Activity

Market Value $1.33b, Prior: $1.38b
New Purchases 0 stocks
Added To 1 stocks
Sold out of 2 stocks
Reduced holdings in 1 stocks
Top 10 Holdings % 100%
Turnover %[1] 28.57%
Turnover Alt %[2] 0.18%
Time Held Top 20 19.1429 quarters
Time Held Top 10 15.4286 quarters
Time Held All 19.14 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance